Neuropsychiatric complications of liver transplantation

Metabolic Brain Disease

Volumn 16, Issue 1-2, 2001, Pages 3-11

  Stracciari, Andrea ^a   Guarino, Maria ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Immunosuppression neurotoxicity; Liver transplantation; Neuropsychiatric complications; Treatment

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

AKINETIC MUTISM; CEREBELLUM DISEASE; CEREBROVASCULAR DISEASE; DISEASE SEVERITY; HEADACHE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LEUKOENCEPHALOPATHY; LIVER TRANSPLANTATION; MENTAL DISEASE; METABOLIC DISORDER; MORTALITY; MOTOR DYSFUNCTION; MYOPATHY; NEUROLOGIC DISEASE; NEUROPATHY; PARESTHESIA; POSTOPERATIVE COMPLICATION; RESTLESS LEGS SYNDROME; REVIEW; SEIZURE; SLEEP DISORDER; SPEECH DISORDER; SURVIVAL; TREMOR;

BRAIN DISEASES; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS;

EID: 0035162471     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011698526025     Document Type: Review

References (44)

1. Aseptic meningitis following cardiac transplantation: Clinical characteristics and relationship to immunosuppressive regimen
2. Neurological complications following liver transplantation
3. Central pontine myelinolisis. A hitherto undescribed disease occurring in alcoholic and malnourished patients
4. Early neurological complications in liver transplantation
5. Polyneuropathy complicating bone marrow and solid organ transplantation
6. Central nervous system lesions in liver transplant recipients: Prospective assessment of indications for biopsy and implications for management
7. Loss of speech after orthotopic liver transplantation
8. Demyelinating sensorimotor polyneuropathy after administration of FK506
9. Neuromuscular disorders
10. OKT3 encephalopathy
11. Immunosuppressants, immunophilins and the nervous system
12. Cyclosporine: A review and its specific use in liver transplantation
13. Alcoholism and organ transplantation
14. Neurological complications of immunosuppressive agents
15. Central pontine myelinolisis after liver transplantation
16. Cerebrovascular complications after orthotopic liver transplantation: A clinico-pathological study
17. Cyclosporine neurotoxicity: A review
18. Speech disorders in transplant recipients taking cyclosporine
19. Headache induced by immunosuppressive agents in transplant recipients
20. A prospective study on the neurological complications after liver transplantation
21. No neurological improvement after liver transplantation in Wilson's disease
22. Neurological complications of liver transplantation
23. A reversible posterior leukoencephalopathy syndrome
24. Psychiatric complications of organ transplantation
25. Movement disorders as sequelae of central pontine myelinolisis: Report of three cases
26. The neuropathology of organ transplantation
27. Neurologic complications of liver transplantation
28. Neurological complications of liver transplantation in adult versus pediatric patients
29. Neurologic complications in liver transplantation
30. Neurological complications of organ transplantation
31. De novo malignant lesions of the Central Nervous System
32. Predictive factors of inhospital CNS complications following liver transplantation
33. Central pontine myelinolisis associated with cyclosporin in liver transplantation
34. Treatment-refractory cyclosporine-associated headache. Relief with conversion to FK-506
35. Neuromuscular complications of orthotopic liver transplantation
36. Tacrolimus: An update of its pharmacology and clinical efficacy in the management of organ transplantation
37. Cyclosporin associated headache
38. Cyclosporine-induced hypertension after transplantation
39. Association between cyclosporin neurotoxicity and hypomagnesaemia
40. Neurologic complications of liver transplantation
41. Neurologic manifestations of immunosuppressive agents
42. Sensorimotor neuropathy resembling CIDP in patients receiving FK506
43. Neuromuscular complications associated with liver transplantation
44. Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients